|
SphygmoCor Vx
 Pulse Wave Velocity Arterial stiffness is a major cause of cardiovascular
disease. Increases in arterial stiffness increase
central systolic & pulse pressure, and demand on the
left ventricle, and decrease the perfusion pressure
through the coronary arteries, thereby increasing the
risk of heart attacks, heart failure and stroke. Pulse wave velocity is a well-established technique for
obtaining a measure of arterial stiffness between two
locations in the arterial tree. The velocity of the
pulse wave along an artery is dependent on the stiffness
of that artery. Most commonly, pulse wave velocity is measured between
the carotid and femoral peripheral artery sites in order
to provide a measure of aortic stiffness. This aortic
pulse wave velocity increases rapidly with age,
typically doubling between the ages of 30 and 60. The SphygmoCor Pulse Wave Velocity Vx System is sold as
an add-on to Px System, and measures the velocity of the
blood pressure waveform between any two superficial
artery sites. It uses a single-lead ECG and then a
tonometer to measure the pressure pulse waveform
sequentially in the two peripheral artery sites (eg.
carotid & femoral). When used in conjunction with the
SphygmoCor Px System, the system provides a
comprehensive assessment of the clinical significance of
the arterial stiffness measured.
Features & Benefits
SphygmoCor Vx Pulse Wave Velocity System is an
add-on package to the SphygmoCor Px Non-Invasive Aortic Blood
Pressure System.
Regulatory Status
-
IEC/EN 60601-1 (amendment 1 & 2)
& IEC/EN 60601-1-2 (AS/NZS 3200.1.0 AS/NZS 3200.1.2)
Electromedical Safety Certification (this is a
mandatory requirement for medical equipment to be
used in hospitals in some countries). Rating – “Type
CF Class 2”
-
Device listing with the
Australian Therapeutic Goods Administration (TGA)
-
CE Mark (MDD Annex II)
-
MLHW registration for Japan
-
KFDA Approval for Korea
-
Import License for China
|
Features & Benefits